THE AZELAPRAG CLINICAL TRIALS DIARIES

AMG 986 exposures improved nonlinearly with rising doses; nominal accumulation was noticed. In HF with reduced ejection portion clients, there have been numerical improves in percent adjustments from baseline in LV ejection fraction and stroke volume by volumetric assessment with AMG 986 vs placebo (stroke quantity boost not recapitulated by Dopple